Cholesterol-lowering treatment is associated with improvement in coronary vascular remodeling and endothelial function in patients with normal or mildly diseased coronary arteries.

Coronary vascular remodeling and altered endothelial function have been described in the early stages of native atherosclerosis. The purpose of this study was to evaluate the association between cholesterol-lowering therapy and coronary vascular remodeling and endothelial function in patients with normal or mildly diseases coronary arteries. Patients (N=101) with normal or mildly diseased coronary arteries by coronary angiography underwent intravascular ultrasound examination of the left anterior descending coronary artery. Vessel and lumen area, atherosclerotic plaque area, and plaque morphology were evaluated. Vascular reactivity was examined with the use of intracoronary adenosine, acetylcholine, and nitroglycerin. Patients were divided into 3 groups based on the total cholesterol levels: group 1 (n=25), patients with a history of hypercholesterolemia adequately treated (total cholesterol <240 mg/dL); group 2 (n=26), patients with hypercholesterolemia not adequately controlled (total cholesterol >/=240 mg/dL); and group 3 (n=50), patients without hypercholesterolemia. Vessel area and lumen area were significantly greater in groups 1 and 3 than in group 2 (for respective values in groups 1, 2, and 3: vessel area 11.9+/-0.5, 10.6+/-0.4, and 11.8+/-0.4 mm(2), both P<0.05; lumen area 8.3+/-0.4, 6.9+/-0.3, and 8.9+/-0.3 mm(2), both P<0.01). However, plaque areas in groups 1 and 2 were similar. Furthermore, acetylcholine-induced percent increases in coronary blood flow were significantly greater in groups 1 and 3 than in group 2 (for respective values in groups 1, 2, and 3: 70.5+/-20.1%, 22.8+/-13.7%, and 68.6+/-14.8%, both P<0. 05). Cholesterol-lowering treatment is associated with an improvement in coronary lumen area that results not from a decrease in plaque area but from an increase in vessel area, reflecting vascular remodeling. Additionally, this adaptive process may occur in association with an improvement of endothelium-dependent vasodilation of the resistance coronary artery.

[1]  HOMAS,et al.  The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels , 2000 .

[2]  David Brieger,et al.  Textbook of interventional cardiology , 1999 .

[3]  Eric J. Topol,et al.  Textbook of Interventional Cardiology , 1999 .

[4]  E J Topol,et al.  Artery size, neointima, and remodeling: time for some standards. , 1998, Journal of the American College of Cardiology.

[5]  R. Schwartz,et al.  Experimental hypercholesterolemia induces ultrastructural changes in the internal elastic lamina of porcine coronary arteries. , 1998, Atherosclerosis.

[6]  E L Ritman,et al.  Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. , 1998, The Journal of clinical investigation.

[7]  R. Gibbons,et al.  Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. , 1997, Circulation.

[8]  D. Heistad,et al.  Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[9]  D. Waters,et al.  Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction. , 1995, Circulation.

[10]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[11]  S. Azen,et al.  Compensatory vascular changes of remote coronary segments in response to lesion progression as observed by sequential angiography from a controlled clinical trial. , 1995, Circulation.

[12]  S. Ellis,et al.  Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation. , 1995, Journal of the American College of Cardiology.

[13]  M. Bell,et al.  Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. , 1995, Circulation.

[14]  A. Tajik,et al.  Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound. , 1995, Journal of the American College of Cardiology.

[15]  G J Boerma,et al.  Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). , 1995, Circulation.

[16]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. , 1995, The New England journal of medicine.

[17]  Scandinavian Simvastatin Survival Study Group.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.

[18]  M-heart investigators.  Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS) , 1994, The Lancet.

[19]  J. Stengård,et al.  Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease , 1994, The Lancet.

[20]  J. Isner,et al.  Focal compensatory enlargement of human arteries in response to progressive atherosclerosis. In vivo documentation using intravascular ultrasound. , 1994, Circulation.

[21]  M. Sugimachi,et al.  Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. , 1994, Circulation.

[22]  R. Erbel,et al.  Extent of atherosclerosis and remodeling of the left main coronary artery determined by intravascular ultrasound. , 1994, The American journal of cardiology.

[23]  L. Wilkins.  National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). , 1994 .

[24]  T M Morgan,et al.  Remodeling of coronary arteries in human and nonhuman primates. , 1994, JAMA.

[25]  L. Wilkins,et al.  National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). , 1994, Circulation.

[26]  Stanley Azen,et al.  Coronary Angiographic Changes with Lovastatin Therapy: The Monitored Atherosclerosis Regression Study (MARS) , 1993, Annals of Internal Medicine.

[27]  J D Thomas,et al.  Toward the quiescent coronary plaque. , 1993, Journal of the American College of Cardiology.

[28]  A M Zeiher,et al.  Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. , 1993, The Journal of clinical investigation.

[29]  C. Lau,et al.  Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients , 1993, The Lancet.

[30]  J. Albers,et al.  Lipid Lowering and Plaque Regression New Insights Into Prevention of Plaque Disruption and Clinical Events in Coronary Disease , 1993, Circulation.

[31]  J. Hermiller,et al.  In vivo validation of compensatory enlargement of atherosclerotic coronary arteries. , 1993, The American journal of cardiology.

[32]  M. Sugimachi,et al.  Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. , 1993, The Journal of clinical investigation.

[33]  H. M. Payne,et al.  Validation of A Doppler Guide Wire for Intravascular Measurement of Coronary Artery Flow Velocity , 1992, Circulation.

[34]  F J Pinto,et al.  Nitroglycerin‐Induced Coronary Vasodilation in Cardiac Transplant Recipients: Evaluation With In Vivo Intracoronary Ultrasound , 1992, Circulation.

[35]  Walter L. Henry,et al.  Intravascular Ultrasound Imaging of Human Coronary Arteries In Vivo: Analysis of Tissue Characterizations With Comparison to In Vitro Histological Specimens , 1991, Circulation.

[36]  R. Kerber,et al.  Coronary arterial remodeling studied by high-frequency epicardial echocardiography: an early compensatory mechanism in patients with obstructive coronary atherosclerosis. , 1991, Journal of the American College of Cardiology.

[37]  J J Albers,et al.  Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. , 1990, The New England journal of medicine.

[38]  T. Bashore,et al.  Intravascular ultrasonography versus digital subtraction angiography: a human in vivo comparison of vessel size and morphology. , 1990, Journal of the American College of Cardiology.

[39]  J. Vane,et al.  Regulatory functions of the vascular endothelium. , 1990, The New England journal of medicine.

[40]  A J Tajik,et al.  Intravascular ultrasound imaging: in vitro validation and pathologic correlation. , 1990, Journal of the American College of Cardiology.

[41]  A. Yeung,et al.  Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. , 1990, Circulation.

[42]  J. Schofer,et al.  Impact of compensatory enlargement of atherosclerotic coronary arteries on angiographic assessment of coronary artery disease. , 1989, Circulation.

[43]  Ronald M. Lauer,et al.  National Cholesterol Education Program. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction: executive summary. National Heart, Lung and Blood Institute, National Institutes of Health. , 1991, Archives of internal medicine.

[44]  D. Ku,et al.  Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. , 1988, Archives of pathology & laboratory medicine.

[45]  C. Zarins,et al.  Compensatory enlargement of human atherosclerotic coronary arteries. , 1987, The New England journal of medicine.

[46]  S Glagov,et al.  Shear stress regulation of artery lumen diameter in experimental atherogenesis. , 1987, Journal of vascular surgery.

[47]  V. Fuster,et al.  Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo. , 1987, Circulation.

[48]  P. Wilson,et al.  Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. , 1986, JAMA.

[49]  S. Grundy.  Cholesterol and coronary heart disease. A new era. , 1986, JAMA.

[50]  J. Neaton,et al.  Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). , 1986, JAMA.

[51]  R. F. Donaldson,et al.  Attenuation of the media of coronary arteries in advanced atherosclerosis. , 1986, The American journal of cardiology.

[52]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[53]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[54]  B L Langille,et al.  Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. , 1986, Science.

[55]  V. Fuster,et al.  Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. , 1985, Circulation research.

[56]  R. Furchgott.  Role of endothelium in responses of vascular smooth muscle. , 1983, Circulation research.

[57]  Bond Mg,et al.  Complicating factors in evaluating coronary artery atherosclerosis. , 1981 .

[58]  Complicating factors in evaluating coronary artery atherosclerosis. , 1981, Artery.

[59]  T Togawa,et al.  Adaptive regulation of wall shear stress to flow change in the canine carotid artery. , 1980, The American journal of physiology.

[60]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[61]  C. Levene,et al.  Medial thinning in atheroma. , 1953, The Journal of pathology and bacteriology.